MBS changes from 1 August 2026
In forceCompared with the 1 July 2026 schedule.
- New items
- 1
- Removed items
- 0
- Updated descriptors
- 0
- Fee changes
- 0
New items
| Item | Schedule fee |
|---|---|
| 73331P7Genetic testing of tumour tissue for RET gene variants in patients with confirmed medullary thyroid cancer to assess eligibility for PBS-listed treatments, requested by a specialist. | $400.00 |